A prospective multicenter study on mucormycosis in India: Epidemiology, diagnosis, and treatment.


Journal

Medical mycology
ISSN: 1460-2709
Titre abrégé: Med Mycol
Pays: England
ID NLM: 9815835

Informations de publication

Date de publication:
01 Jun 2019
Historique:
received: 05 04 2018
revised: 21 06 2018
accepted: 12 07 2018
pubmed: 8 8 2018
medline: 30 4 2019
entrez: 8 8 2018
Statut: ppublish

Résumé

Mucormycosis due to Mucorales is reported at large numbers in uncontrolled diabetics across India, but systematic multicenter epidemiological study has not been published yet. The present prospective study was conducted at four major tertiary care centers of India (two in north and two in south India) during 2013-2015 to compare the epidemiology, treatment strategies and outcome of mucormycosis between the two regions. Molecular techniques were employed to confirm the identity of the isolates or to identify the agent in biopsy samples. A total of 388 proven/probable mucormycosis cases were reported during the study period with overall mortality at 46.7%. Uncontrolled diabetes (n = 172, 56.8%) and trauma (n = 31, 10.2%) were the common risk factors. Overall, Rhizopus arrhizus (n = 124, 51.9%) was the predominant agent identified, followed by Rhizopus microsporus (n = 30, 12.6%), Apophysomyces variabilis (n = 22, 9.2%) and Rhizopus homothallicus (n = 6, 2.5%). On multivariate analysis, the mortality was significantly associated with gastrointestinal (OR: 18.70, P = .005) and pulmonary infections (OR: 3.03, P = .015). While comparing the two regions, majority (82.7%) cases were recorded from north India; uncontrolled diabetes (n = 157, P = .0001) and post-tubercular mucormycosis (n = 21, P = .006) were significantly associated with north Indian cases. No significant difference was noted among the species of Mucorales identified and treatment strategies between the two regions. The mortality rate was significantly higher in north Indian patients (50.5%) compared to 32.1% in south India (P = .016). The study highlights higher number of mucormycosis cases in uncontrolled diabetics of north India and emergence of R. microsporus and R. homothallicus across India causing the disease.

Identifiants

pubmed: 30085158
pii: 5063412
doi: 10.1093/mmy/myy060
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

395-402

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.

Auteurs

Hariprasath Prakash (H)

Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Anup Kumar Ghosh (AK)

Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Shivaprakash Mandya Rudramurthy (SM)

Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Pankaj Singh (P)

Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Immaculata Xess (I)

Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.

Jayanthi Savio (J)

Department of Microbiology, St. John's Medical College, Bengaluru, Karnataka, India.

Umabala Pamidimukkala (U)

Department of Microbiology, Nizam's Institute of Medical Sciences, Hyderabad, Telangana, India.

Joseph Jillwin (J)

Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Subhash Varma (S)

Department of Internal medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Ashim Das (A)

Department of Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Naresh K Panda (NK)

Department of Otolaryngology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Surjit Singh (S)

Department of Paediatric Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Amanjit Bal (A)

Department of Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Arunaloke Chakrabarti (A)

Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH